BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 32360245)

  • 1. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
    Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
    Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
    Urganci N; Kepil N; Ergun S; Bakkaloglu OK
    J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study.
    Caccese M; Ius T; Simonelli M; Fassan M; Cesselli D; Dipasquale A; Cavallin F; Padovan M; Salvalaggio A; Gardiman MP; Skrap M; Zagonel V; Lombardi G
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of MSI Cancer: Facts and Hopes.
    Wilbur HC; Le DT; Agarwal P
    Clin Cancer Res; 2024 Apr; 30(8):1438-1447. PubMed ID: 38015720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population.
    Sini MC; Doro MG; Frogheri L; Zinellu A; Paliogiannis P; Porcu A; Scognamillo F; Delogu D; Santeufemia DA; Persico I; Palomba G; Maestrale GB; Cossu A; Palmieri G
    J Transl Med; 2024 Jan; 22(1):108. PubMed ID: 38280995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report.
    Aluisio G; Mazzeo E; Lohr F; Fiocchi F; Bettelli S; Baldessari C; Paterlini M; Bruni A
    J Med Case Rep; 2020 Dec; 14(1):239. PubMed ID: 33287897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATR inhibition induces synthetic lethality in mismatch repair-deficient cells and augments immunotherapy.
    Wang M; Ran X; Leung W; Kawale A; Saxena S; Ouyang J; Patel PS; Dong Y; Yin T; Shu J; Manguso RT; Lan L; Wang XF; Lawrence MS; Zou L
    Genes Dev; 2023 Oct; 37(19-20):929-943. PubMed ID: 37932012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients.
    Venetis K; Fusco N; Sajjadi E
    Front Oncol; 2021; 11():735476. PubMed ID: 34660298
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
    Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
    Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational spectrum and precision oncology for biliary tract carcinoma.
    Lin J; Cao Y; Yang X; Li G; Shi Y; Wang D; Long J; Song Y; Mao J; Xie F; Bai Y; Zhang L; Yang X; Wan X; Wang A; Guan M; Zhao L; Hu K; Pan J; Huo L; Lu X; Mao Y; Sang X; Zhang H; Wang K; Wang X; Zhao H
    Theranostics; 2021; 11(10):4585-4598. PubMed ID: 33754015
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma.
    Huffman BM; Ellis H; Jordan AC; Freed-Pastor WA; Perez K; Rubinson DA; Sethi N; Singh H; Surana R; Wolpin BM; Aguirre AJ; Cleary JM
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy.
    Chen X; Li J; Chen Y; Que Z; Du J; Zhang J
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus impacts on expression of DNA mismatch repair protein PMS2 and tumor microenvironment in pancreatic ductal adenocarcinoma.
    Pan X; Mizukami H; Hara Y; Yamada T; Yamazaki K; Kudoh K; Takeuchi Y; Sasaki T; Kushibiki H; Igawa A; Hakamada K
    J Diabetes Investig; 2023 Jan; 14(1):132-144. PubMed ID: 36453157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy.
    Hou W; Yang B; Zhu H
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers.
    Amato M; Franco R; Facchini G; Addeo R; Ciardiello F; Berretta M; Vita G; Sgambato A; Pignata S; Caraglia M; Accardo M; Zito Marino F
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways.
    Yin C; Alqahtani A; Noel MS
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and Future Therapies for Pancreatic Ductal Adenocarcinoma.
    Sally Á; McGowan R; Finn K; Moran BM
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.
    Yang Y; Ding Y; Gong Y; Zhao S; Li M; Li X; Song G; Zhai B; Liu J; Shao Y; Zhu L; Pang J; Ma Y; Ou Q; Wu X; Zhang Z
    BMC Cancer; 2022 Feb; 22(1):186. PubMed ID: 35180847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline Variants in DNA Damage Repair Genes: An Emerging Role in the Era of Precision Medicine in Pancreatic Adenocarcinoma.
    Shoucair S; Baker AR; Yu J
    Ann Gastroenterol Surg; 2022 Jan; 6(1):7-16. PubMed ID: 35106410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Paradigms for Older Adults with Pancreatic Cancer: a Nuanced Approach.
    Winer A; Dotan E
    Curr Treat Options Oncol; 2021 Oct; 22(11):104. PubMed ID: 34596801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.